health news today obesity drugs glp-1 The revolution: What UAB researchers are discovering about how these work World Health Organization recommends GLP-1

Who Should Avoid These Medications Pregnancy and breastfeeding: Not recommended due to limited safety data

Medical Science Monitor

This includes adjustment for the sample design and geographic stratification of the cell phone sample, within household probability of selection, and the design of the panel-recruitment procedure

Quality assessment was performed using the Cochrane risk-of-bias tool

Basic science and clinical research evidence indicates that GLP-1RAs produce direct immunomodulatory actions that function separately from weight loss

Segment and regional forecasting covering semaglutide, exenatide, and next-generation molecules, alongside indication-specific demand trajectories across diabetes, obesity, and cardiovascular risk reduction